Artal Group S.A. - CIDARA THERAPEUTICS INC ownership

CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 57 filers reported holding CIDARA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of CIDARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$170
-99.9%
224,6750.0%0.01%
+50.0%
Q3 2022$141,000
+28.2%
224,6750.0%0.01%0.0%
Q2 2022$110,000
-41.2%
224,6750.0%0.01%
-25.0%
Q1 2022$187,000
-34.4%
224,6750.0%0.01%0.0%
Q4 2021$285,000
-43.3%
224,6750.0%0.01%
-27.3%
Q3 2021$503,000
+10.8%
224,6750.0%0.01%
+22.2%
Q2 2021$454,000
-24.1%
224,6750.0%0.01%
-18.2%
Q1 2021$598,000
+33.2%
224,6750.0%0.01%
+10.0%
Q4 2020$449,000
-29.8%
224,6750.0%0.01%
-37.5%
Q3 2020$640,000
-26.7%
224,675
-5.0%
0.02%
-33.3%
Q2 2020$873,000236,5000.02%
Other shareholders
CIDARA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,627,670$1,533,5911.88%
5AM Venture Management, LLC 1,134,511$1,068,9360.31%
Nantahala Capital Management 2,538,406$2,391,6860.20%
BVF INC/IL 6,861,127$6,464,5540.17%
Monashee Investment Management LLC 369,099$347,7650.14%
West Family Investments, Inc. 368,910$347,5870.12%
JEPPSON WEALTH MANAGEMENT, LLC 137,560$129,6090.06%
XTX Topco Ltd 202,758$191,0390.03%
GSA CAPITAL PARTNERS LLP 136,974$1290.01%
Callan Capital, LLC 103,462$97,4820.01%
View complete list of CIDARA THERAPEUTICS INC shareholders